EP1007570A4 - Monospezifische antikörper gegen fibrinogen und fibrinopeptide - Google Patents

Monospezifische antikörper gegen fibrinogen und fibrinopeptide

Info

Publication number: EP1007570A4
Authority: EP; European Patent Office
Prior art keywords: fibrinopeptide; fpb; provides; antibodies; monospecific
Prior art date: 1997-07-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

EP98935874A

Other languages

English (en)

French (fr)

Other versions

EP1007570A1 (de

EP1007570B1 (de

Inventor

Bohdan J Kudryk

Colvin M Redman

Jian-Zhong Zhang

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

New York Blood Center Inc

Original Assignee

New York Blood Center Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-25

Filing date

1998-07-22

Publication date

2005-02-23

1998-07-22 Application filed by New York Blood Center Inc filed Critical New York Blood Center Inc

2000-06-14 Publication of EP1007570A1 publication Critical patent/EP1007570A1/de

2005-02-23 Publication of EP1007570A4 publication Critical patent/EP1007570A4/de

2009-06-10 Application granted granted Critical

2009-06-10 Publication of EP1007570B1 publication Critical patent/EP1007570B1/de

2018-07-22 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/972—Modified antibody, e.g. hybrid, bifunctional
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
General Physics & Mathematics (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Microbiology (AREA)
Biophysics (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pathology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP98935874A 1997-07-25 1998-07-22 Monospezifische antikörper gegen fibrinogen und fibrinopeptide b Expired - Lifetime EP1007570B1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US900660		1997-07-25
US08/900,660 US5876947A (en)	1997-07-25	1997-07-25	Monospecific antibody reactive with Fibrinogen and fibrinopeptide B
PCT/US1998/015059 WO1999005176A1 (en)	1997-07-25	1998-07-22	Monospecific antibody reactive with fibrinogen and fibrinopeptide b

Publications (3)

Publication Number	Publication Date
EP1007570A1 EP1007570A1 (de)	2000-06-14
EP1007570A4 true EP1007570A4 (de)	2005-02-23
EP1007570B1 EP1007570B1 (de)	2009-06-10

Family

ID=25412892

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP98935874A Expired - Lifetime EP1007570B1 (de)	1997-07-25	1998-07-22	Monospezifische antikörper gegen fibrinogen und fibrinopeptide b

Country Status (7)

Country	Link
US (1)	US5876947A (de)
EP (1)	EP1007570B1 (de)
AT (1)	ATE433463T1 (de)
AU (1)	AU8503898A (de)
DE (1)	DE69840895D1 (de)
ES (1)	ES2328306T3 (de)
WO (1)	WO1999005176A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19910102B4 (de) *	1999-03-08	2006-06-01	Fischer, Markus, Dr.rer.nat.	Proteinkonjugate, Verfahren, Vektoren, Proteine und DNA zu deren Herstellung, deren Verwendung, sowie Arzneimittel und Impfstoffe mit einem Gehalt derselben
US20040014158A1 (en) *	1999-03-08	2004-01-22	Adelbert Bacher	Protein conjugates, methods, vectors, proteins and DNA for producing them, their use, and medicaments and vaccines containing a certain quantity of said protein conjugates
US6673561B1 (en)	1999-06-30	2004-01-06	Regents Of The University Of California	Diagnostic test for thrombotic or thromboembolic disease
WO2001001150A2 (en) *	1999-06-30	2001-01-04	Regents Of The University Of California	Diagnostic test for thrombotic or thromboembolic disease
US7828741B2 (en) *	2002-12-20	2010-11-09	The Charlotte-Mecklenburg Hospital Authority	Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia
DE60326988D1 (de) *	2002-12-20	2009-05-14	Charlotte Mecklenburg Hospital	Wegwerf-handvorrichtung zum auffangen von ausgeatmetem atemkondensat
WO2004073497A2 (en) *	2003-02-14	2004-09-02	The Charlotte-Mecklenburg Hospital Authority	Device and method for collection of exhaled alveolar breath condensate
JP4695591B2 (ja) *	2003-06-18	2011-06-08	アポセンスリミテッド	アポトーシス細胞を選択的に標的化する方法、および、それらに用いられる低分子物質リガンド
DE102004009400A1 (de)	2004-02-24	2005-09-08	Zlb Behring Gmbh	Fibrinogen Reinigung
EP2118656B1 (de) *	2006-12-29	2012-08-29	Abbott Laboratories	Verbessertes testverfahren für immunsuppressiva
US20100204145A1 (en) *	2007-09-11	2010-08-12	Dorian Bevec	Use of a peptide as a therapeutic agent
US8900822B2 (en)	2011-11-21	2014-12-02	Ethicon, Inc.	Fibrinogen assay

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH03287070A (ja) *	1990-04-03	1991-12-17	Tosoh Corp	フィブリノペプタイドＢβ↓１‐↓４↓２の測定法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1338841C (en) *	1988-06-10	1997-01-14	Bohdan J. Kudryk	Monoclonal antibodies specific for human fibrinopeptide a

1997
- 1997-07-25 US US08/900,660 patent/US5876947A/en not_active Expired - Lifetime
1998
- 1998-07-22 DE DE69840895T patent/DE69840895D1/de not_active Expired - Lifetime
- 1998-07-22 ES ES98935874T patent/ES2328306T3/es not_active Expired - Lifetime
- 1998-07-22 AT AT98935874T patent/ATE433463T1/de not_active IP Right Cessation
- 1998-07-22 WO PCT/US1998/015059 patent/WO1999005176A1/en not_active Ceased
- 1998-07-22 EP EP98935874A patent/EP1007570B1/de not_active Expired - Lifetime
- 1998-07-22 AU AU85038/98A patent/AU8503898A/en not_active Abandoned

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH03287070A (ja) *	1990-04-03	1991-12-17	Tosoh Corp	フィブリノペプタイドＢβ↓１‐↓４↓２の測定法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199206, Derwent World Patents Index; Class B04, AN 1992-044244, XP002312186 *
PROCYK R ET AL: "Accessibility of epitopes on fibrin clots and fibrinogen gels.", BLOOD. 1 APR 1991, vol. 77, no. 7, 1 April 1991 (1991-04-01), pages 1469 - 1475, XP002312184, ISSN: 0006-4971 *

Also Published As

Publication number	Publication date
ES2328306T3 (es)	2009-11-11
WO1999005176A1 (en)	1999-02-04
DE69840895D1 (de)	2009-07-23
EP1007570A1 (de)	2000-06-14
EP1007570B1 (de)	2009-06-10
ATE433463T1 (de)	2009-06-15
AU8503898A (en)	1999-02-16
US5876947A (en)	1999-03-02

Legal Events

Date	Code	Title	Description
2000-04-28	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2000-06-14	17P	Request for examination filed	Effective date: 20000215
2000-06-14	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2005-02-23	A4	Supplementary search report drawn up and despatched	Effective date: 20050110
2008-02-13	17Q	First examination report despatched	Effective date: 20080114
2008-12-08	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2009-04-21	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2009-05-08	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2009-05-27	RIN1	Information on inventor provided before grant (corrected)	Inventor name: ZHANG, JIAN-ZHONG Inventor name: REDMAN, COLVIN, M. Inventor name: KUDRYK, BOHDAN, J.
2009-06-10	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2009-06-10	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D
2009-06-15	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2009-07-22	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2009-07-23	REF	Corresponds to:	Ref document number: 69840895 Country of ref document: DE Date of ref document: 20090723 Kind code of ref document: P
2009-07-31	REG	Reference to a national code	Ref country code: CH Ref legal event code: NV Representative=s name: ISLER & PEDRAZZINI AG
2009-10-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090610
2009-10-30	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: IE Payment date: 20090728 Year of fee payment: 12 Ref country code: ES Payment date: 20090727 Year of fee payment: 12
2009-11-02	NLV1	Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
2009-11-11	REG	Reference to a national code	Ref country code: ES Ref legal event code: FG2A Ref document number: 2328306 Country of ref document: ES Kind code of ref document: T3
2009-11-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090910 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090610
2009-11-30	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: AT Payment date: 20090721 Year of fee payment: 12
2010-02-26	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090731 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090610
2010-03-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091010
2010-04-16	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2010-04-16	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2010-04-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090610
2010-05-19	26N	No opposition filed	Effective date: 20100311
2010-10-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090911
2011-03-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090610
2011-04-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090722
2011-05-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100722
2011-07-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100722
2011-08-18	REG	Reference to a national code	Ref country code: ES Ref legal event code: FD2A Effective date: 20110818
2011-09-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090610
2011-10-31	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: CH Payment date: 20110725 Year of fee payment: 14
2011-11-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100723
2012-10-31	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: GB Payment date: 20120725 Year of fee payment: 15
2012-12-31	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: FR Payment date: 20120731 Year of fee payment: 15 Ref country code: DE Payment date: 20120727 Year of fee payment: 15
2014-02-28	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2014-03-26	GBPC	Gb: european patent ceased through non-payment of renewal fee	Effective date: 20130722
2014-04-24	REG	Reference to a national code	Ref country code: DE Ref legal event code: R119 Ref document number: 69840895 Country of ref document: DE Effective date: 20140201
2014-04-25	REG	Reference to a national code	Ref country code: FR Ref legal event code: ST Effective date: 20140331
2014-04-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130731 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130731 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130722 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140201
2014-05-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130731

Publication	Publication Date	Title
AU689777B2 (en)	1998-04-09	Assay for cardiac troponin I
SE9500023D0 (sv)	1995-01-04	Method of detecting cancer
ATE322558T1 (de)	2006-04-15	Sensible und multiplexe diagnostische tests zur proteinanalyse
DE69840669D1 (de)	2009-04-30	Pca3, pca3-gene und verfahren zu ihrer verwendung
CO4870792A1 (es)	1999-12-27	Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata
SE9604575D0 (sv)	1996-12-12	Method and system for analyte determination
EP1007570A4 (de)	2005-02-23	Monospezifische antikörper gegen fibrinogen und fibrinopeptide
Rao et al.	1979	Reactive sulfhydryl groups of the band 3 polypeptide from human erythroycte membranes. Location in the primary structure.
CA2193323C (en)	2005-08-16	Process for preparing a synthetic calibrator for use in sandwich immunoassays, which calibrator consists of an antibody against one of the antibodies used in the assay and of a sequence of the analyte
ATE196804T1 (de)	2000-10-15	Test für thrombosegefahr
CN101470117A (zh)	2009-07-01	一种定量检测人自身抗体的化学发光配体分析方法
CA2499926A1 (en)	2004-04-08	Antibody against von willebrand factor cleaving enzyme and assay system using the same
KR20150041620A (ko)	2015-04-16	Pivka-ⅱ 측정 방법, 측정 시약 및 측정 키트
JP2002542820A5 (de)	2007-06-14
ES2185104T3 (es)	2003-04-16	Eliminacionde las interferencias en procedimientos de diagnostico mediante peptidos de d-aminoacidos.
KR870008186A (ko)	1987-09-24	면역글로부린 Al(IgAl) 단면 분석에 의한 임질진단방법, 그 시약 및 키트(kit)
US20090075298A1 (en)	2009-03-19	Method of analyzing enzyme
CA2077906A1 (en)	1992-07-11	Method for measurement of tissue factor in high sensitivity and measurement kit therefor
JPH05500001U (de)	1993-02-04
JPH05295000A (ja)	1993-11-09	共有結合的交雑種抗体、その調製法およびこれを使用する均質的免疫検定法
DE69123723D1 (de)	1997-01-30	Diagnostisches verfahren und reagenz für hiv
BR9815090A (pt)	2000-10-17	"moléculas de ácido nucléico correlacionadas com o fenótipo rhesus d fraco"
DE69606024D1 (de)	2000-02-10	Feststellung von antikörperproduktion
Hearn et al.	1980	The preparation and partial characterization of antigenic fractions obtained from the mycelial walls of several Aspergillus species
WO2002063048B1 (en)	2003-11-06	Methods for predicting sensitivity of tumors to arginine deprivation